297 related articles for article (PubMed ID: 14670128)
1. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
2. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.
Aboody KS; Brown A; Rainov NG; Bower KA; Liu S; Yang W; Small JE; Herrlinger U; Ourednik V; Black PM; Breakefield XO; Snyder EY
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12846-51. PubMed ID: 11070094
[TBL] [Abstract][Full Text] [Related]
3. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
[TBL] [Abstract][Full Text] [Related]
4. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
5. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.
Ito S; Natsume A; Shimato S; Ohno M; Kato T; Chansakul P; Wakabayashi T; Kim SU
Cancer Gene Ther; 2010 May; 17(5):299-306. PubMed ID: 19893595
[TBL] [Abstract][Full Text] [Related]
6. Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma.
Lin D; Najbauer J; Salvaterra PM; Mamelak AN; Barish ME; Garcia E; Metz MZ; Kendall SE; Bowers M; Kateb B; Kim SU; Johnson M; Aboody KS
Neuroimage; 2007; 37 Suppl 1():S18-26. PubMed ID: 17560798
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
[TBL] [Abstract][Full Text] [Related]
8. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma.
Shimato S; Natsume A; Takeuchi H; Wakabayashi T; Fujii M; Ito M; Ito S; Park IH; Bang JH; Kim SU; Yoshida J
Gene Ther; 2007 Aug; 14(15):1132-42. PubMed ID: 17508009
[TBL] [Abstract][Full Text] [Related]
9. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
[TBL] [Abstract][Full Text] [Related]
10. Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.
Portnow J; Synold TW; Badie B; Tirughana R; Lacey SF; D'Apuzzo M; Metz MZ; Najbauer J; Bedell V; Vo T; Gutova M; Frankel P; Chen M; Aboody KS
Clin Cancer Res; 2017 Jun; 23(12):2951-2960. PubMed ID: 27979915
[No Abstract] [Full Text] [Related]
11. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.
Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH
Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958
[TBL] [Abstract][Full Text] [Related]
12. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.
Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS
Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
Kim JH; Kim JY; Kim SU; Cho KG
Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
[TBL] [Abstract][Full Text] [Related]
14. VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.
Jin G; Zhou Y; Chai Q; Zhu G; Xu F; Liu F
J Cancer Res Clin Oncol; 2013 Mar; 139(3):475-83. PubMed ID: 23180018
[TBL] [Abstract][Full Text] [Related]
15. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
17. Neural stem cell tropism to glioma: critical role of tumor hypoxia.
Zhao D; Najbauer J; Garcia E; Metz MZ; Gutova M; Glackin CA; Kim SU; Aboody KS
Mol Cancer Res; 2008 Dec; 6(12):1819-29. PubMed ID: 19074827
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
Yuan X; Hu J; Belladonna ML; Black KL; Yu JS
Cancer Res; 2006 Mar; 66(5):2630-8. PubMed ID: 16510582
[TBL] [Abstract][Full Text] [Related]
19. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
[TBL] [Abstract][Full Text] [Related]
20. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.
Joo KM; Park IH; Shin JY; Jin J; Kang BG; Kim MH; Lee SJ; Jo MY; Kim SU; Nam DH
Mol Ther; 2009 Mar; 17(3):570-5. PubMed ID: 19127251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
